Podoplanin: An emerging cancer biomarker and therapeutic target

Podoplanin (PDPN) is a transmembrane receptor glycoprotein that is upregulated on transformed cells, cancer associated fibroblasts and inflammatory macrophages that contribute to cancer progression. In particular, PDPN increases tumor cell clonal capacity, epithelial mesenchymal transition, migratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Harini, Rayes, Julie, Miyashita, Tomoyuki, Ishii, Genichiro, Retzbach, Edward P., Sheehan, Stephanie A., Takemoto, Ai, Chang, Yao‐Wen, Yoneda, Kazue, Asai, Jun, Jensen, Lasse, Chalise, Lushun, Natsume, Atsushi, Goldberg, Gary S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980289/
https://www.ncbi.nlm.nih.gov/pubmed/29575529
http://dx.doi.org/10.1111/cas.13580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980289/
https://www.ncbi.nlm.nih.gov/pubmed/29575529
http://dx.doi.org/10.1111/cas.13580

Ejemplares similares